Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Specimen Handling 4Cyclophosphamide 4Biopsy 4Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3sodium-iodide symporter 2pembrolizumab 2mogamulizumab 2fludarabine phosphate 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Tacrolimus 2Photons 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Busulfan 2Brentuximab Vedotin 2talimogene laherparepvec 1ruxolitinib 1hypericin 1duvelisib 1Vorinostat 1Transplantation 1Sirolimus 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × hypericin × 90 days × Clear all
NCT06470451 2026-04-03

FLASH2

Soligenix

Phase 3 Recruiting
80 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡